CSPC Pharmaceutical Group... (CHJTF)
OTC: CHJTF
· Real-Time Price · USD
1.27
0.00 (0.00%)
At close: Aug 05, 2025, 12:35 PM
CSPC Pharmaceutical Income Statement
Financials in HKD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Revenue | 17.5B | n/a | 16.6B | 7.78B | 8.03B | 8.05B | 17.2B | 18.85B | 17B | 16.59B |
Cost of Revenue | 4.97B | n/a | 4.79B | 2.23B | 2.31B | 2.53B | 4.95B | 5.16B | 4.16B | 3.96B |
Gross Profit | 12.52B | n/a | 11.82B | 5.55B | 5.72B | 5.52B | 12.25B | 13.69B | 12.84B | 12.63B |
Operating Income | 3.98B | n/a | 3.79B | 1.93B | 1.91B | 1.75B | 3.73B | 4.18B | 3.79B | 3.73B |
Interest Income | n/a | n/a | 145.93M | n/a | 141.15M | n/a | 161.64M | 118.91M | 131M | 90M |
Pretax Income | 4.08B | n/a | 4.04B | 1.93B | 1.9B | 1.78B | 4.35B | 4.49B | 3.83B | 4.39B |
Net Income | 3.25B | n/a | 3.14B | 1.53B | 1.54B | 1.43B | 3.51B | 3.58B | 3.08B | 3.67B |
Selling & General & Admin | 5.81B | n/a | 2.44B | 2.45B | 2.69B | 2.75B | 2.52B | 7.23B | 6.85B | 6.96B |
Research & Development | 2.73B | n/a | 2.73B | 1.37B | 1.3B | 1.01B | 2.36B | 2.28B | 2.2B | 1.94B |
Other Expenses | n/a | n/a | 1.79M | 136.94M | n/a | 16.64M | 371.94M | n/a | n/a | n/a |
Operating Expenses | 8.54B | n/a | 8.02B | 3.77B | 4.02B | 3.77B | 8.52B | 9.51B | 9.05B | 8.9B |
Interest Expense | n/a | n/a | 9.02M | 6.16M | 6.29M | 4.43M | 17.02M | 11.74M | 3.49M | 5.74M |
Selling & Marketing Expenses | 5.13B | n/a | 2.11B | 2.13B | 2.41B | 2.49B | 2.22B | n/a | n/a | n/a |
Cost & Expenses | 13.52B | n/a | 12.81B | 6B | 6.33B | 6.31B | 13.47B | 14.67B | 13.21B | 12.85B |
Income Tax Expense | 805.53M | n/a | 748.85M | 341.23M | 311.65M | 311.86M | 738.14M | 836.07M | 732.49M | 664.48M |
Shares Outstanding (Basic) | 11.84B | 11.85B | 11.85B | 11.88B | 11.89B | 11.92B | 11.93B | 11.92B | 11.95B | 11.95B |
Shares Outstanding (Diluted) | 11.84B | 11.85B | 11.85B | 11.88B | 11.89B | 11.92B | 11.93B | 11.92B | 11.95B | 11.96B |
EPS (Basic) | 0.27 | 0.14 | 0.26 | 0.13 | 0.28 | 0.12 | 0.29 | 0.30 | 0.26 | 0.31 |
EPS (Diluted) | 0.27 | 0.14 | 0.26 | 0.13 | 0.28 | 0.12 | 0.29 | 0.30 | 0.26 | 0.31 |
EBITDA | 4.57B | n/a | 4.42B | 1.93B | 1.91B | 1.79B | 4.36B | 4.76B | 4.32B | 4.25B |
EBIT | 3.98B | n/a | 1.79B | 1.93B | 1.91B | 1.75B | 2B | 1.96B | 3.87B | 3.72B |
Depreciation & Amortization | 590.95M | n/a | 630.85M | -39.59K | 599.69M | 40.26M | 634.02M | 580.55M | 525.44M | 515.51M |